TwinStrand Biosciences Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
64
- Latest Deal Type
-
Series C1
- Latest Deal Amount
-
$10.3M
- Investors
-
14
TwinStrand Biosciences General Information
Description
Developer of a deoxyribonucleic acid sequencing therapy designed to identify ultra-low frequency genomic variants that are undetectable by conventional methods. The company's therapy offers highly sensitive and specific duplex sequencing technology and shares data that can help with critical decisions in clinical medicine, public health, and other fields of science on a faster timescale, providing researchers with clearer insights in applications ranging from residual cancer detection to genetic toxicology.
Contact Information
Website
www.twinstrandbio.comCorporate Office
- 3131 Elliott Avenue
- Suite 750
- Seattle, WA 98121
- United States
Corporate Office
- 3131 Elliott Avenue
- Suite 750
- Seattle, WA 98121
- United States
TwinStrand Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series C1) | 30-Jun-2023 | $10.3M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series B) | 30-Apr-2021 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A) | 30-Dec-2019 | Completed | Generating Revenue | |||
| 5. Grant | 15-Jul-2019 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Sep-2017 | $6.1M | $6.1M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Sep-2015 | Completed | Startup |
TwinStrand Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C-2 | ||||||||
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 1,665,992 | $0.000100 | 6% | $2.58 | $2.58 | 1x | $2.58 | 2.61% |
| Seed | 4,365,624 | $0.000100 | 6% | $1.52 | $1.52 | 1x | $1.52 | 6.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
TwinStrand Biosciences Comparisons
Industry
Financing
Details
TwinStrand Biosciences Competitors (35)
One of TwinStrand Biosciences’s 35 competitors is Personal Genome Diagnostics, a Formerly VC-backed company based in Baltimore, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Personal Genome Diagnostics | Formerly VC-backed | Baltimore, MD | ||||
| GnuBIO | Formerly VC-backed | Cambridge, MA | ||||
| Owkin | Venture Capital-Backed | Paris, France | ||||
| Meso Scale Diagnostics | Corporation | Rockville, MD | ||||
| Molecular Cloning Laboratories | Corporation | South San Francisco, CA |
TwinStrand Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TwinStrand Biosciences Patents
TwinStrand Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025529130-A | Method and reagent for detecting circular dna molecules in biological samples | Pending | 29-Aug-2022 | ||
| EP-4581151-A2 | Methods and reagents for detection of circular dna molecules in biological samples | Pending | 29-Aug-2022 | ||
| EP-4581151-A4 | Methods and reagents for detection of circular dna molecules in biological samples | Pending | 29-Aug-2022 | ||
| US-20260258502-A1 | Methods and reagents for detection of circular dna molecules in biological samples | Pending | 29-Aug-2022 | ||
| WO-2024050386-A2 | Methods and reagents for detection of circular dna molecules in biological samples | Inactive | 29-Aug-2022 | C12Q1/6806 |
TwinStrand Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TwinStrand Biosciences Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Janus Henderson Investors | Asset Manager | Minority | ||
| S32 | Venture Capital | Minority | ||
| Soleus Capital | Asset Manager | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Angel (individual) | Minority |
TwinStrand Biosciences FAQs
-
When was TwinStrand Biosciences founded?
TwinStrand Biosciences was founded in 2015.
-
Where is TwinStrand Biosciences headquartered?
TwinStrand Biosciences is headquartered in Seattle, WA.
-
What is the size of TwinStrand Biosciences?
TwinStrand Biosciences has 64 total employees.
-
What industry is TwinStrand Biosciences in?
TwinStrand Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is TwinStrand Biosciences a private or public company?
TwinStrand Biosciences is a Private company.
-
What is the current valuation of TwinStrand Biosciences?
The current valuation of TwinStrand Biosciences is .
-
What is TwinStrand Biosciences’s current revenue?
The current revenue for TwinStrand Biosciences is .
-
How much funding has TwinStrand Biosciences raised over time?
TwinStrand Biosciences has raised $82.7M.
-
Who are TwinStrand Biosciences’s investors?
Janus Henderson Investors, S32, Soleus Capital, Alexandria Venture Investments, and are 5 of 14 investors who have invested in TwinStrand Biosciences.
-
Who are TwinStrand Biosciences’s competitors?
Personal Genome Diagnostics, GnuBIO, Owkin, Meso Scale Diagnostics, and Molecular Cloning Laboratories are some of the 35 competitors of TwinStrand Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
